June 28, 2024 - ITALFARMACO
Artificial intelligence to speed drug discovery breakthroughs
Link to the article
March 21, 2024 - Business Wire
Italfarmaco receives FDA approval for givinostat in Duchenne muscular dystrophy (DMD)
Link to the article
March 19, 2024 - Business Wire
Italfarmaco Publishes in The Lancet Neurology results from Phase 3 EPIDYS Study in Duchenne Muscular Dystrophy (DMD)
Link to the article
September 05, 2023 - Business Wire
Italfarmaco Group Receives EMA Validation of Marketing Authorization Application for Givinostat in Duchenne Muscular Dystrophy
Link to the article
June 29, 2023 - Business Wire
Italfarmaco Group Completes FDA Submission of New Drug Application for Givinostat in Duchenne Muscular Dystrophy and Receives Priority Review
Link to the article
April 01, 2023 - Il Sole 24 Ore
De Santis: we need to train new skills for competition
Link to the article (Only in italian)
June 25, 2022 - Business Wire
Italfarmaco Group Announces Positive Topline Data from Phase 3 Trial Showing Beneficial Effect of Givinostat in Patients with Duchenne Muscular Dystrophy
Link to the article
June 26, 2021 - Business Wire
Italfarmaco Announces Topline Data from Phase 2 Trial with Givinostat in Patients with Becker Muscular Dystrophy
Link to the article
March 25, 2021 - ITALFARMACO
Italfarmaco's commitment against Covid-19
Download PDF (Only in Italian)
Datasheet (Only in Italian)
March 16, 2021 - ITALFARMACO
Italfarmaco Group adds innovative Alzheimer’s disease therapy to its neurology-based product portfolio
Download PDF
February 22, 2021 - Business Wire
Italfarmaco provides an update on the clinical development program of Givinostat in Duchenne Muscular Dystrophy
Link to the article
October 12, 2020 - PharmaStar
Duchenne, givinostat riceve da Fda lo status di farmaco per malattia pediatrica rara.
Link to the article (Only in Italian)
October 12, 2020 - ITALFARMACO
Italfarmaco Receives FDA Rare Pediatric Disease Designation for Givinostat in Duchenne Muscular Dystrophy…
Download PDF
June 12, 2020 - interprogetti editori
Combination Products integrated into the corporate Quality System of the Pharmaceutical Industries
Link to the article (Only in Italian)
May 26, 2020 - Il Giorno (edizione Milano)
Virus and coagulation risk: x-ray medical records - Interview with Dr. Paolo Zamboardi - Italfarmaco Spa
Link to the article (Only in Italian)
May 14, 2020 - adnkronos
Coronavirus, Italfarmaco donates 250 thousand Ppe to the Lombardy Region
Link to the article (Only in Italian)
April 30, 2020 - Il Sole 24 Ore
Confindustria, varata la squadra di presidenza. Bonomi: caos misure fase 2, incerte e contraddittorie. Dieci vicepresidenti elettivi e tre di diritto.
Link to the article (Only in Italian)
April 30, 2020 - la Repubblica
Confindustria, la squadra di Bonomi. Gubitosi e Beltrame vicepreseidenti.
Link to the article (Only in Italian)
April 30, 2020 - la Repubblica
Coronavirus the first Italian registry on the link with thrombosis
Link to the article (Only in Italian)
April 27, 2020 - PharmaStar
Thromboembolic complications from Covid-19, the first Italian register starts
Link to the article (Only in Italian)
April 27, 2020 - BusinessWire
Italfarmaco Provides Update on Advanced-Stage Clinical Development Program with Givinostat in Duchenne Muscular Dystrophy
Link to the article
March 26, 2020 - Aboutpharma Online
Italian Pharmaceutical: from 13 companies support for family doctors
Link to the article (Only in Italian)
February 12, 2020 - BeBeez
Italfarmaco and Rottapharm Biotech have launched AurorA Science their vehicle dedicated to investing in startups
Link to the article
November 08, 2019 - PHARMACEUTIQUES
"Italian Success Story" of the magazine PHARMACEUTIQUES, n ° 270, Oct 2019
Download PDF
August 01, 2019 - ITALFARMACO
Italfarmaco Enters Binding Term Sheet Agreement with Neupharma for an Exclusive Option to Develop and Commercialize Inhaled Teicoplanin
Download PDF
April 02, 2019 - Il giorno Milano
Biosimilar drugs, new frontier
Download PDF
February 28, 2019 - ITFPHARMA
ITF Pharma has been named an honoree for the 2018 Patient Impact Award, presented by Life Sciences Pennsylvania, for the successful launch and approval of TIGLUTIK
Download PDF
November 30, 2018 - Adnkronos
The project: make the first move take care of your bones. The "awareness" initiative on osteoporosis is supported by Abiogen and Italfarmaco and will interest 11 scientific societies involved in the study of metabolic bone diseases.
Link to the article
September 06, 2018 - ITFPHARMA
ITF PHARMA announces FDA approval of TIGLUTIK™ (riluzole) oral suspension for the tratment of amyotrophic lateral sclerosis (ALS)
Download PDF
September 06, 2018 - ABOUTPHARMA ONLINE
Sla, Fda approva riluzolo di Italfarmaco
Download PDF (Only in italian)
June 28, 2017 - Il Giorno Milano
Malattia rara. Un accordo da 5,6 milioni per la ricerca
Download PDF
March 27, 2017 - Il Sole24 Ore
Più calcio e vitamina D per ridurre le fratture da osteoporosi e far risparmiare il Ssn
Link to the article
March 25, 2015 - Pharmakronos
L'accordo Chemi-Teva dà i suoi frutti
Link to the article
February 25, 2015 - Pharmastar
Distrofia di Duchenne, bene in fase II il givinostat, farmaco di ricerca Italfarmaco
Link to the article
March 01, 2014 - Espansione
L'industria farmaceutica in un mondo che cambia - Tavola Rotonda. Il settore farmaceutico, tra attualità e prospettive.
Link to the article
December 13, 2013 - Helsinn.com
Helsinn and Italfarmaco reinforce their alliance through the grant of rights to phase-III ghrelin receptor agonist Anamorelin in Italy
Link to the article
November 27, 2013 - Aziende storiche di Milano
Presentation of book "Aziende storiche di Milano" (Historical Companies of Milan), edited by the Circolo Filologico Milanese, with the participation of the Chamber of Commerce of Milan and with the sponsorship of Expo 2015. The book intends to be an acknowledgement to Milanese Companies with the longest corporate history which, with entrepreneurial continuity, keep pursuing the development and growth of their activity. Italfarmaco SpA, founded in 1938, is deservedly counted among them, and the book contains a dedicated section.
View photos in the Media Gallery